Mark Vignola
Director of Finance/CFO at TERNS PHARMACEUTICALS, INC.
Net worth: 552 559 $ as of 2024-05-30
Mark Vignola active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Director of Finance/CFO | 2020-08-10 | - |
| Treasurer | 2020-12-31 | - |
Career history of Mark Vignola
Former positions of Mark Vignola
| Companies | Position | Start | End |
|---|---|---|---|
| APPLIED THERAPEUTICS, INC. | Director of Finance/CFO | 2019-04-28 | 2020-04-30 |
| INTERCEPT PHARMACEUTICALS, INC. | Investor Relations Contact | 2015-05-31 | 2019-04-30 |
| Corporate Officer/Principal | 2017-12-31 | 2019-04-30 | |
Needham & Co. LLC
 Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies. | Analyst-Equity | 2011-06-30 | 2015-04-30 |
| Duke University Medical Center | Corporate Officer/Principal | 2010-12-31 | 2010-12-31 |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Corporate Officer/Principal | 1999-12-31 | 1999-12-31 |
Training of Mark Vignola
| Boston College | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
| Duke University | Graduate Degree |
Statistics
International
| United States | 10 |
Operational
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 2 |
| Analyst-Equity | 1 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| APPLIED THERAPEUTICS, INC. | Health Technology |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Needham & Co. LLC
Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies. | Finance |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
- Stock Market
- Insiders
- Mark Vignola
- Experience
